<DOC>
	<DOC>NCT02267876</DOC>
	<brief_summary>The purpose of the study is to assess the cumulative disease detection of greater than or equal to Cervical intraepithelial neoplasia 2 (CIN2) and greater than or equal to Cervical intraepithelial neoplasia 3 (CIN3) in the subjects over 3 years using the subject's HPV status and cytology status from the BDS-USHPV baseline results</brief_summary>
	<brief_title>Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Subject enrolled into the protocol BDSUSHPV and identified as eligible for the longitudinal protocol â€¢ Subjects enrolled into protocol BDSUSHPV with a baseline colposcopy and biopsy procedure and not treated. Subjects with prior complete or partial hysterectomy involving removal of the cervix Subjects on whom conization, LEEP, cervical laser surgery, or cryosurgery has been performed since enrollment into the BDSUSHPV study Year 3 visit can not exceed 3 years and 6 months from the baseline visit</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>